| PERIOD ENDING | 27-Sep-09 | 28-Jun-09 | 29-Mar-09 | 28-Dec-08 | | Total Revenue | 749 | 655 | 198 | 1,043 | | Cost of Revenue | 554 | 202 | 434 | 582 | | | Gross Profit | 195 | 453 | (236) | 461 | | | Operating Expenses | | Research Development | 7,141 | 6,973 | 6,800 | 5,309 | | Selling General and Administrative | 2,600 | 3,136 | 2,509 | 2,506 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (9,546) | (9,656) | (9,545) | (7,354) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,331 | 100 | 1 | 1,505 | | Earnings Before Interest And Taxes | (4,215) | (9,556) | (9,544) | (5,849) | | Interest Expense | 695 | 1,201 | 810 | 320 | | Income Before Tax | (4,910) | (10,757) | (10,354) | (6,169) | | Income Tax Expense |
-
|
-
|
-
|
-
| | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (4,910) | (10,757) | (10,354) | (6,169) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (4,910) | (10,757) | (10,354) | (6,169) | | Preferred Stock And Other Adjustments | (144) |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($5,054) | ($10,757) | ($10,354) | ($6,169) |
|
0.51% Nasdaq 
Income Statement
